HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
CATX
Perspective Therapeutics Inc
Healthcare Medical Devices · Washington, USA · Reports in usd
Market Cap: $335.3M
Market Cap
$335.3M
Enterprise Val
$193.8M
P/E Ratio
-3.25
P/B Ratio
1.62
Trailing PEG (1Y)
0.20
As Of
Apr 23, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$207.0M
Gross Margin100.00%
Profit Margin100.00%
Return on Equity-41.27%
Return on Assets-34.32%
Current Ratio5.17
Debt/Equity0.02
LT Debt/Equity0.01
Revenue Per Share0.00

Income Statement

Dec 31, 2025
Revenue$43.0K
Cost of Revenue$0.00
Gross Profit$43.0K
R&D$32.9M
SG&A$7.0M
Operating Expenses$39.9M
Operating Income-$39.8M
Interest Expense$64.0K
Tax Expense-$793.0K
Net Income-$37.5M
EPS (Basic)$-0.51
EPS (Diluted)$-0.51
EBIT-$38.2M
EBITDA-$37.2M
Consolidated Income-$37.5M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$30.6M
Accounts Receivable$6.0K
Inventory$0.00
Current Assets$148.4M
LT Investments$0.00
Property, Plant & Equipment$78.1M
Intangibles$40.0M
Non-Current Assets$118.6M
Total Assets$267.0M
Accounts Payable$20.5M
Current Debt$679.0K
Current Liabilities$28.7M
LT Debt$2.6M
Non-Current Liabilities$31.3M
Total Liabilities$59.9M
Total Debt$3.3M
Retained Earnings-$334.8M
Shareholder Equity$207.0M
Shares Outstanding74,337,990

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow-$24.7M
Investing Cash Flow$28.5M
Financing Cash Flow-$13.0K
CapEx-$5.1M
Free Cash Flow-$29.7M
Depreciation & Amort.$1.0M
Stock-Based Comp$2.3M
Acquisitions / Disposals$0.00
Investment Activity$33.7M
Debt Issued/Repaid-$13.0K
Equity Issued/Repaid$0.00
Dividends Paid$0.00
Net Change in Cash$3.9M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h